Identification of microRNA profiles in salivary adenoid cystic carcinoma cells during metastatic progression

Chen,Wei; Zhao,Xiaoge; Dong,Zhen; Cao,Gang; Zhang,Senlin

doi:10.3892/ol.2014.1975

Identification of microRNA profiles in salivary adenoid cystic carcinoma cells during metastatic progression

Authors:
- Wei Chen
- Xiaoge Zhao
- Zhen Dong
- Gang Cao
- Senlin Zhang
View Affiliations

Affiliations: Department of Stomatology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, P.R. China, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710061, P.R. China, Department of Stomatology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, P.R. China
Published online on: March 14, 2014 https://doi.org/10.3892/ol.2014.1975
Pages: 2029-2034

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Salivary adenoid cystic carcinoma (SACC) is a common type of salivary gland cancer. The poor long‑term prognosis of patients with SACC is primarily due to local recurrence, distant metastasis and perineural invasion. MicroRNAs (miRNAs) have been identified as important post‑transcriptional regulators, which are involved in various biological processes. The aim of the present study was to identify the miRNA expression profiles that are involved in the metastatic progression of SACC. Therefore, microarray technology was employed to identify miRNA expression profiles in an SACC cell line, ACC‑2, and a highly metastatic SACC cell line, ACC‑M, which was screened from ACC‑2 by a combination of in vivo selection and cloning in vitro. Differences in miRNA expression were assessed by quantitative polymerase chain reaction (qPCR) assay. In addition, the potential target genes that are regulated by selected miRNAs were analyzed by various target prediction tools. The microarray data revealed that the levels of 38 miRNAs significantly differed between the ACC‑M cells and the control ACC‑2 cells. Six miRNAs (miR‑4487, ‑4430, ‑486‑3p, ‑5191, ‑3131 and ‑211‑3p) were selected to validate the microarray data via qPCR. The expression of two miRNAs (miR‑4487 and ‑4430) was significantly upregulated in the ACC‑M cells, while the expression of two other miRNAs (miR‑5191 and ‑3131) was significantly downregulated in the ACC‑M cells. The potential target genes that were identified to be controlled by the six selected miRNAs were divided into four groups according to function, as follows: Apoptosis and proliferation (46 genes), cell cycle (30 genes), DNA damage and repair (24 genes) and signaling pathway (30 genes). The identification of microRNA expression profiles in highly metastatic SACC cells may provide an improved understanding of the mechanisms involved in metastatic progression, which would aid in the development of novel strategies for the treatment of SACC.

View Figures

View References

1	Renehan A, Gleave EN, Hancock BD, Smith P and McGurk M: Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centre. Br J Surg. 83:1750–1754. 1996. View Article : Google Scholar : PubMed/NCBI
2	Anderson JN Jr, Beenken SW, Crowe R, Soong SJ, Peters G, Maddox WA and Urist MM: Prognostic factors in minor salivary gland cancer. Head Neck. 17:480–486. 1995. View Article : Google Scholar : PubMed/NCBI
3	van der Wal JE, Becking AG, Snow GB and van der Waal I: Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck. 24:779–783. 2002.PubMed/NCBI
4	Ramer N, Wu H, Sabo E, Ramer Y, Emanuel P, Orta L and Burstein DE: Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Cancer. 116:77–83. 2010.PubMed/NCBI
5	Chen W, Zhang HL, Shao XJ, Jiang YG, Zhao XG, Gao X, Li JH, Yang J, Zhang YF, Liu BL and Sun MY: Gene expression profile of salivary adenoid cystic carcinoma associated with perineural invasion. Tohoku J Exp Med. 212:319–334. 2007. View Article : Google Scholar : PubMed/NCBI
6	Nakashima D, Uzawa K, Kasamatsu A, Koike H, Endo Y, Saito K, Hashitani S, Numata T, Urade M and Tanzawa H: Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands. Int J Cancer. 118:704–713. 2006. View Article : Google Scholar
7	Chen W, Zhang H, Wang J, Cao G, Dong Z, Su H, Zhou X and Zhang S: Lentiviral-mediated gene silencing of Notch-4 inhibits in vitro proliferation and perineural invasion of ACC-M cells. Oncol Rep. 29:1794–1804. 2013.
8	Ding LC, She L, Zheng DL, Huang QL, Wang JF, Zheng FF and Lu YG: Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma. Oncol Rep. 24:363–368. 2010.PubMed/NCBI
9	Yang X, Zhang P, Ma Q, Kong L, Li Y, Liu B and Lei D: EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo. Cancer Biol Ther. 13:85–91. 2012. View Article : Google Scholar : PubMed/NCBI
10	Luukkaa H, Klemi P, Hirsimäki P, Vahlberg T, Kivisaari A, Kähäri VM and Grénman R: Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer. Acta Otolaryngol. 128:482–490. 2008. View Article : Google Scholar : PubMed/NCBI
11	Hao L, Xiao-lin N, Qi C, Yi-ping Y, Jia-quan L and Yan-ning L: Nerve growth factor and vascular endothelial growth factor: retrospective analysis of 63 patients with salivary adenoid cystic carcinoma. Int J Oral Sci. 2:35–44. 2010. View Article : Google Scholar : PubMed/NCBI
12	Costa AF, Tasso MG, Mariano FV, Soares AB, Chone CT, Crespo AN, Fresno MF, Llorente JL, Suárez C, de Araújo VC, Hermsen M and Altemani A: Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation. Histopathology. 60:816–825. 2012.
13	Chekanova JA and Belostotsky DA: MicroRNAs and messenger RNA turnover. Methods Mol Biol. 342:73–85. 2006.PubMed/NCBI
14	Lages E, Ipas H, Guttin A, Nesr H, Berger F and Issartel JP: MicroRNAs: molecular features and role in cancer. Front Biosci (Landmark Ed). 17:2508–2540. 2012. View Article : Google Scholar
15	Li C, Hashimi SM, Good DA, Cao S, Duan W, Plummer PN, Mellick AS and Wei MQ: Apoptosis and microRNA aberrations in cancer. Clin Exp Pharmacol Physiol. 39:739–46. 2012. View Article : Google Scholar : PubMed/NCBI
16	Nishizawa T and Suzuki H: The role of microRNA in gastric malignancy. Int J Mol Sci. 14:9487–9496. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J and Sung JJ: MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
18	Guan XF, Qiu WL, He RG and Zhou XJ: Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int J Oral Maxillofac Surg. 26:116–119. 1997. View Article : Google Scholar : PubMed/NCBI
19	Vela J, Vitorica J and Ruano D: Rapid PCR-mediated synthesis of competitor molecules for accurate quantification of beta(2) GABA(A) receptor subunit mRNA. Brain Res Brain Res Protoc. 8:184–190. 2001. View Article : Google Scholar : PubMed/NCBI
20	Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, et al: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 29:365–371. 2001. View Article : Google Scholar : PubMed/NCBI
21	Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC and Wu XN: Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett. 5:1639–1642. 2013.PubMed/NCBI
22	Margue C, Philippidou D, Reinsbach SE, Schmitt M, Behrmann I and Kreis S: New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion. PLoS One. 8:e734732013. View Article : Google Scholar : PubMed/NCBI
23	Nikitina EG, Urazova LN and Stegny VN: MicroRNAs and human cancer. Exp Oncol. 34:2–8. 2012.
24	Matsuba HM, Spector GJ, Thawley SE, Simpson JR, Mauney M and Pikul FJ: Adenoid cystic salivary gland carcinoma. A histopathologic review of treatment failure patterns. Cancer. 57:519–524. 1986. View Article : Google Scholar : PubMed/NCBI
25	Kim KH, Sung MW, Chung PS, Rhee CS, Park CI and Kim WH: Adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 120:721–726. 1994. View Article : Google Scholar : PubMed/NCBI
26	Wiseman SM, Popat SR, Rigual NR, Hicks WL Jr, Orner JB, Wein RO, McGary CT and Loree TR: Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases. Ear Nose Throat J. 81:510–517. 2002.PubMed/NCBI
27	Fordice J, Kershaw C, El-Naggar A and Goepfert H: Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 125:149–152. 1999. View Article : Google Scholar : PubMed/NCBI
28	Sequeiros-Santiago G, García-Carracedo D, Fresno MF, Suarez C, Rodrigo JP and Gonzalez MV: Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands. Oncol Rep. 21:1215–1222. 2009.PubMed/NCBI
29	He Q, Zhou X, Li S, Jin Y, Chen Z, Chen D, Cai Y, Liu Z, Zhao T and Wang A: MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway. Biochim Biophys Acta. 1830:5258–5266. 2013. View Article : Google Scholar : PubMed/NCBI
30	Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM and El-Naggar AK: MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17–92 upregulation with poor outcome. PLoS One. 8:e667782013.PubMed/NCBI
31	Liu L, Hu Y, Fu J, Yang X and Zhang Z: MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma. J Oral Pathol Med. 42:140–147. 2013. View Article : Google Scholar : PubMed/NCBI
32	Pinós T, Barbosa-Desongles A, Hurtado A, Santamaria-Martínez A, de Torres I, Reventós J and Munell F: Human SHBG mRNA translation is modulated by alternative 5′-non-coding exons 1A and 1B. PLoS One. 5:e138442010.PubMed/NCBI